Edinburgh
The Future: Cures, Clinics, and Hope
Tomorrow’s Medicine, Available Today

We envision a world where FDA-approved CGT therapies are accessible nationwide—transforming care for patients and families across the U.S.

Science Backed
Patient Focused
Rome
The Now: Powering the Science
Breakthroughs Aren’t Born in a Vacuum

Every major discovery in cell and gene therapy is made possible by the researchers we support—and the ecosystem we’ve built to empower them.

Science Backed
Patient Focused
Osaka
The Beginning: Where It All Starts
It All Begins with One Person

Behind every innovation is a donor—a human being who chose to give others a fighting chance. This is where the future of medicine truly begins.

Science Backed
Patient Focused

"CGT Global is on a mission to transform the life science and medical industries. Our commitment is to expedite research, accelerate clinical trials, streamline the commercialization process, and broaden patient access to life-changing therapies" Cate Spears, Founder and CEO

We are CGT Global

We’re not just supplying the starting materials for cell and gene therapy.


We’re building the foundation for research, for access, and for the clinics of tomorrow.

From discovery to commercialization, CGT Global supports the world’s leading researchers with ethically sourced, high-quality human blood and bone marrow products — collected, processed, and delivered with unmatched care.

Trusted Leadership Driving Innovation in Oncology and Rare Disease

Clinical development in oncology and rare diseases is becoming increasingly complex. Success depends on expertly navigating evolving regulatory pathways and overcoming unique challenges at every stage. At CGT Global, our leadership team combines decades of deep expertise in these specialized fields to guide your program with precision and insight.

Our experience in managing complex indications accelerates milestone achievement, drives positive clinical outcomes, and—most importantly—helps patients gain access to breakthrough therapies. With CGT Global as your partner, you benefit from a leadership team dedicated to advancing innovation and delivering reliable, tailored support throughout your cell and gene therapy journey.

Specialized Capabilities for Every Stage of Cell & Gene Therapy Development

Leverage CGT Global’s integrated donor-to-delivery infrastructure to eliminate inefficiencies and accelerate progress. Our coordinated approach connects biospecimen sourcing, specialty lab services, and clinical trial support—streamlining your path from discovery to commercialization.

Enhance Early Phase Development

From Research to Real Lives.

Successfully navigate the complexities of early phase cell and gene therapy development with CGT Global’s integrated clinical and laboratory sciences capabilities. With over 25 years of oncology and immunotherapy experience, we help anticipate and mitigate risks such as complex kitting, sample management, and regulatory challenges—keeping your program on track from day one.

Accelerate Late Phase Development

Because Every Patient Deserves a Future.

Expand your clinical programs with assurance through CGT Global’s proven expertise in late phase development. Our comprehensive solutions—from premium biospecimen procurement to GMP-compliant processing and streamlined logistics—deliver dependable quality and consistency as you progress toward successful commercialization.

 

Driving Discovery for a Healthier Tomorrow

At CGT Global, we’re proud to contribute to a field that has the power to transform lives. Sharing expertise and data enhances our collective progress—together, we amplify innovation. By fostering collaboration and open exchange, we accelerate the journey from breakthrough science to accessible therapies, bringing new hope to patients everywhere.